Medicine

Using AI to Create New Parkinson’s Treatments: Q&A with Mattias Alder

April 22, 2024 - By 

Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.

Related Posts

FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk

February 19, 2025

Navigating Distrust: Pharma in the Age of Social Media

February 19, 2025

Pharmaceutical Executive: February 2025 Issue (PDF)

February 18, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *